Sign in
4

Changes in Ownership

Viridian Therapeutics, Inc.\DE Filed Acc 0001104659-22-092992

Director bought 425,531 shares at $23.50 ($9,999,979)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Fairmount Funds Management LLC Director 2022-08-17 Purchase +425,531 $23.50 $9,999,979 1,363,764 I: show line 1 in the form
Open-market purchases · 425,531 sh · avg $23.50 · $9,999,979
Loading xslF345X03/tm2224209-1_4seq1.xml…